Literature DB >> 675261

Experimental therapeutics and kinetics: selection and overgrowth of specifically and permanently drug-resistant tumor cells.

H E Skipper, F M Schabel, H H Lloyd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 675261

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  14 in total

1.  The effects of verapamil and a tiapamil analogue, DMDP, on adriamycin-induced cytotoxicity in P388 adriamycin-resistant and -sensitive leukemia in vitro and in vivo.

Authors:  S Radel; I Bankusli; E Mayhew; Y M Rustum
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Potentiation of antitumor agents by calcium channel blockers with special reference to cross-resistance patterns.

Authors:  T Tsuruo; H Kawabata; N Nagumo; H Iida; Y Kitatani; S Tsukagoshi; Y Sakurai
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

3.  Relationship between glutathione levels and drug or radiation sensitivities in human gastric cancer cell lines in vitro.

Authors:  S C Barranco; B Weintraub; K K MacLean; E G Beasley; V K Jenkins; C M Townsend
Journal:  Invest New Drugs       Date:  1991-02       Impact factor: 3.850

4.  Cure of advanced L1210 leukemia after correction of abnormal red blood cell deformability.

Authors:  M H Cohen
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

5.  Potentiation of doxorubicin cytotoxicity by the calcium antagonist bepridil in anthracycline-resistant and -sensitive cell lines. A comparison with verapamil.

Authors:  G J Schuurhuis; H J Broxterman; J J van der Hoeven; H M Pinedo; J Lankelma
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

6.  P-glycoprotein expression and modulation of cell-membrane morphology in adriamycin-resistant P388 leukemia cells.

Authors:  S Radel; W Fredericks; E Mayhew; R Baker
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

7.  The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells.

Authors:  D Fink; S Nebel; P S Norris; S Aebi; H K Kim; M Haas; S B Howell
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

8.  Tumour response to chemotherapy in animals that have been treated with the same drugs prior to tumour implantation: a model for studying host effects on apparent drug resistance.

Authors:  C K Luk; I F Tannock
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

9.  Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.

Authors:  T C Stephens; K Adams; J H Peacock
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

10.  Clonal variation in the sensitivity of a murine mammary carcinoma to melphalan.

Authors:  T J McMillan; T C Stephens; G G Steel
Journal:  Br J Cancer       Date:  1986-06       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.